Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma
Advanced Drug Delivery Reviews · 2026
DOI: 10.1016/j.addr.2025.115759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026. Verfasst von Alaa Zam und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, Lo…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Nucleic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 250 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Tumor Charity, Brain Research UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK.
- Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicine, King's College London, Franklin-Wilkins Building, 150 Stamford Street, London, SE1 9NH, UK; Department of Pharmacology and Pharmacy, Li Ka Shin…
Förderung
- Brain Tumor Charity
- Brain Research UK
Zitieren
APA
Zam, A., Rouatbi, N., Walters, A. A., & Al-Jamal, K. T. (2026). Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2025.115759
Vancouver
Zam A, Rouatbi N, Walters AA, Al-Jamal KT. Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma. Advanced Drug Delivery Reviews. 2026. doi:10.1016/j.addr.2025.115759
BibTeX
@article{Zam2026,
author = {Zam, Alaa and Rouatbi, Nadia and Walters, Adam A and Al-Jamal, Khuloud T},
title = {Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
doi = {10.1016/j.addr.2025.115759}
}
EUVIMED